Objectives: Chlorhexidine is used as a disinfectant to prevent surgical infections. Recently, studies have indicated that chlorhexidine usage has selected methicillin-resistant Staphylococcus aureus strains that are tolerant to chlorhexidine and that this may be related to the presence of the qacA/B-encoded efflux pumps. Here, we evaluated if high-level exposure to chlorhexidine selects for tolerant colonizing Staphylococcus epidermidis and we addressed the consequences of long-term exposure to chlorhexidine.
Introduction
Human and animal health and welfare relies, in part, on our ability to properly clean and disinfect our immediate surroundings. Biocides are used for this purpose worldwide and in all kinds of settings, including industry, animal and food production, home settings, institutions and in the healthcare sector. In hospitals, where invasive procedures and foreign body materials are commonly used, the failure of proper disinfection and antiseptics is highlighted by the occurrence of hospital-acquired and foreign body-related infections. The commonly used biocide chlorhexidine was first described in 1954 and was approved for use in the USA in the 1970s. In Denmark it was included in the first national guideline for disinfection in the healthcare sector printed in 1979. 1 -3 Currently, chlorhexidine is recommended in Danish national guidelines for pre-surgery hand disinfection, surgery skin site disinfection and in the pre-emptive eradication therapy of methicillin-resistant Staphylococcus aureus (MRSA) carriers. 2, 4, 5 Several studies have been conducted to evaluate chlorhexidine for skin disinfection and for efficacy, tolerability, resistance and cross-resistance risks in different genera. However, there are still important knowledge gaps, especially concerning the roles of resistance and crossresistance. 6 -9 Recently, a clinical study suggested that the qacA/ B locus found in a MRSA outbreak strain belonging to the multilocus sequence type ST239 could explain the increased survival of this strain. 10 They found that an antiseptic protocol based on chlorhexidine reduced endemic MRSA strains (where ,5% carried qacA/B genes), but had no effect on ST239 strains. 10 Low-level mupirocin resistance combined with carriage of the qacA/B locus has been found to independently predict failure of MRSA eradication. 11 A study in Hong Kong found that 56.7% of nurses compared with only 13.5% of the general population were colonized with qacA/ B-positive coagulase-negative staphylococci. The qacA/B-positive coagulase-negative staphylococci were significantly more resistant to methicillin while S. aureus with qacA/B genes were multiresistant. 12 Thus, there are clinical indications that for staphylococci the use of chlorhexidine may be linked with a higher prevalence of qacA/B genes and tolerance towards chlorhexidine.
For staphylococcus, most studies have focused on S. aureus, while only a few have investigated coagulase-negative staphylococci. 12, 13 Staphylococcus epidermidis is the most frequently isolated coagulase-negative staphylococci from human epithelia, 14 as well as the most common cause of nosocomial bloodstream infections 15 and foreign body-associated infections. 16 Those infections are characterized by the ability of S. epidermidis to adhere to and proliferate on foreign body materials. 17 They are often multiresistant and difficult to treat with antibiotics and cure may necessitate removal of the colonized device. 16, 18 The most well-characterized resistance determinant in staphylococcus providing tolerance to chlorhexidine is the gene qacA, encoding a multidrug resistance efflux pump capable of exporting chlorhexidine. 19 The qacA gene has been correlated with increased MBCs for S. aureus and the expression of the gene is induced by chlorhexidine. 10, 19, 20 However, in some cases qacA is present in S. aureus without affecting the MIC/MBC of chlorhexidine; conversely, qacA may be absent in strains displaying tolerance to chlorhexidine. 9 A number of other qac genes encode efflux pumps with different biocide specificities. 21 The qacB gene is closely related to the qacA gene, differing only in 7 -9 bp; however, the QacB pump has less affinity towards chlorhexidine, indicating that it is less important than QacA in chlorhexidine tolerance. 19, 22 Most studies do not distinguish between the presence of qacA and qacB when detected by PCR, thereby giving rise to the designation qacA/B.
Here, we address if the widespread use of chlorhexidine in the Danish hospital setting has selected for S. epidermidis strains with tolerance towards chlorhexidine and/or harbours the qacA/B genes and if those genes are associated with more antibiotic resistance. We investigated a large number of S. epidermidis isolates from healthy colonized people, scrub nurses heavily exposed to chlorhexidine, current isolates from blood and blood isolates from the pre-chlorhexidine era.
Methods
Sample collection, staphylococcal isolation and identification S. epidermidis were collected from nurses and patients recruited at the Copenhagen University Hospital, Hvidovre, Denmark. We recruited eight scrub nurses working within the sterile field, using the hand rub Iduscrub (85% denatured ethanol, 0.5% chlorhexidine/0.5% glycerol) (Brenntag Nordic A/S) as the last step in the disinfecting hand procedure performed before surgery. They were sampled on a Friday when disinfecting hand hygiene had been performed for a minimum of 3 of the last 4 days. Samples were collected in the morning before any hand disinfection had been performed that day. Nurses were excluded if they had received antibiotics during the last 3 months. In addition, 10 patients going through a planned joint replacement programme were recruited. They were sampled twice. The first sample was taken before hospitalization and the next sample was taken the day after hospitalization and joint replacement surgery. Patients were excluded if they had been hospitalized, had received antibiotics or had used hand disinfectants for the previous 3 months.
All samples were collected and handled by the investigator. Each nurse or patient was sampled by swabbing the dominant hand (the palm of the hand proximal to the thumb, the palm of the hand proximal to the little finger, all fingertips and interdigital sites) with one swab and a nasal swab from both nares. The swabs were directly inoculated on SaSelect agar plates (63748, SaSelect, Bio-Rad Laboratories, Denmark). After 24 and 48 h of incubation colonies with a different appearance (colour and morphology) were isolated and identified using the VITEK 2 system with the GP ID Card (Gram-positive bacterial identification; product number 21342, bioMérieux). All isolates identified as S. epidermidis were included and later confirmed by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS; Bruker Daltronics with Bruker Daltonics MALDI biotyper software 2.0). Isolates were stored at 2808C until use.
Other S. epidermidis included
A total of 107 S. epidermidis from our collection of blood isolates, foreign body infections and environmental isolates was also studied. S. epidermidis ATCC 12228 was used as a reference strain. See Table 1 for further details.
Unless otherwise stated, the isolates were grown on either tryptic soy agar (Oxoid, Roskilde, Denmark) or 5% blood agar (677, SSI diagnostica, Denmark). All incubations were performed at 378C in atmospheric air.
Biocides
The chlorhexidine commercial products studied were Iduscrub (Brenntag Nordic A/S) and Hibiscrub (Mö lnlycke Health Care ApS). For MIC/MBC, 20% chlorhexidine digluconate (Brenntag Nordic A/S) and 96% ethanol (KEMETYL A/S, Denmark) were purchased and user concentrations were constituted to be comparable to the commercial products. Products were diluted in Mueller-Hinton broth (MHB) (Oxoid) for susceptibility testing. Table 2 provides an overview.
Susceptibility testing
Antibiotic susceptibility was determined using the disc diffusion method (Oxoid discs, Roskilde, Denmark) following the European Committee on Antimicrobial Susceptibility Testing guidelines and breakpoints. 23, 24 The MICs and MBCs of the different biocide solutions were determined following the recommendations of the BSAC using broth microdilutions. 25 Briefly, 100 mL of an overnight bacterial suspension adjusted to 10 6 cfu/mL+100 mL of the biocide dilution (Table 2 ) was mixed in each well. The MIC was determined as the lowest concentration that inhibited visible growth after 24 h. Positive and negative controls were included in each measurement. An aliquot of 10 mL from each well was, after 24 h of incubation, spotted on to MuellerHinton agar (Oxoid) plates containing no biocide. The MBC was read as the lowest concentration with no growth after 48 h. All MIC/MBC experiments were carried out in duplicate. ATCC 12228 (Table 1) was included in each experiment as a quality control and as a test of reproducibility of the method in general.
qacA/B gene detection
The presence of qacA/B and arcC was determined by PCR and gel electrophoresis. Template DNA was prepared by suspending colonies from an overnight culture in Milli-Q water, heating for 10 min at 1008C and centrifuging at 4293 g for 2 min and then the supernatant was used immediately or frozen at 2208C. The qacA/B gene was amplified by PCR using the primers 5
′ -TTGCACCCGGATTAGCGGCG-3 
Statistical analysis
The results were analysed using GraphPad Prism version 6.00 for Windows (GraphPad Software, La Jolla, CA, USA; www.graphpad.com). The MIC/MBC results were compared using the non-parametric Mann-Whitney test. Categorical variables were compared using Fisher's exact test.
Ethics
This study protocol was submitted to the local ethics committee. They replied (letter H-3-2009-104) that ethics approval for this study was not required since we were only working with the bacterial isolates and there was no material relating to humans as defined in the law (Lov nr. 402 af 28. maj 2003 § 7, nr. 1.). However, each sampled patient and nurse was given written information about the project and gave his or her verbal consent to participate in the study. Approval was given by the Danish Data Protection Agency to save data on sampled persons for 1 year (Datatilsynet, J. nr. 2009-41-3827). After all sample collections were completed, personal identification data were deleted and the only material saved was the isolated bacteria with information on which study group it was isolated from and the date and site of isolation. Bacteria isolates from the same patient were numbered pairwise.
Results

Isolation of S. epidermidis from patients and nurses in Denmark
We isolated 23 S. epidermidis from eight scrub nurses with 2 -4 different isolates obtained from each. From 10 patients (non-users of chlorhexidine), 26 S. epidermidis were isolated before hospitalization, representing 1 -5 isolates from each. Also 26 S. epidermidis were obtained from the same 10 patients after hospitalization, representing 1-6 isolates from each. A list of the isolated S. epidermidis is provided in Table 3 .
Use of chlorhexidine was not correlated with tolerance
The MIC and MBC values of various chlorhexidine-containing biocides are presented in Table 4 . The MIC of Iduscrub (given as mg/L chlorhexidine) was almost identical for all patient and scrub nurse isolates, spanning only two doubling dilutions, independent of the origin of isolation, as was the MIC (given as mg/L chlorhexidine) of Hibiscrub, pure chlorhexidine and chlorhexidine + ethanol, which spanned only three doubling dilutions. The MBCs for the isolates in the two groups were also very similar, spanning up to four doubling dilutions. The patient group contained one isolate with an MBC of 15 mg/L when measured by Iduscrub and this was the highest measured MBC among all the S. epidermidis isolates. Skovgaard et al.
However, the MBC for this isolate of chlorhexidine, chlorhexidine + ethanol and Hibiscrub was only 3.75 mg/L. When comparing the MIC and MBC results between the nurses and the patients before hospitalization using the Mann -Whitney test there were indications that the patient isolates were more tolerant than the nurse isolates, with significant P values found for the MBC of Iduscrub (P,0.0001), chlorhexidine +ethanol (P¼ 0.024) and Hibiscrub (P ¼ 0.001) and for the MIC measured for Hibiscrub (P,0.0001). However, this represented differences in their mean values of less than one doubling dilution, and there were no significant differences between nurses and patients when the MBC was measured for chlorhexidine (P ¼ 0.106) or when the MIC was measured for Iduscrub (P ¼ 0.731), chlorhexidine (P .0.999) or chlorhexidine + ethanol (P ¼ 0.534).
MIC/MBC values were not correlated with the presence of qacA/B genes in S. epidermidis Table 3 ). Figure 1 shows the MIC and MBC distributions for isolates from the nurses and from the patients before hospitalization in relation to the qacA/B status of the isolates. The isolate with an MBC of 15 mg/L was qacA/B negative. Grouping the isolates from the nurses and the patients before hospitalization into qacA/B positive or negative and comparing their MIC or MBC values using the Mann -Whitney test revealed that there were no statistically significant differences between isolates being qacA/B positive or negative. P values were 0.44 for the MIC measured for Iduscrub, 0.46 for the MIC measured for chlorhexidine, 0.86 for the MBC measured for Iduscrub and 0.63 for the MBC measured for chlorhexidine.
We also investigated if qacA/B genes were prevalent in isolates that were successful in establishing an infection. It is notable that the S. epidermidis isolates that have caused joint replacement infections were equally susceptible towards chlorhexidine measured by MIC/MBC as the other examined isolates (P values between 0.303 and .0.999, when compared with isolates from patients before hospitalization, Mann -Whitney test) and only one of the four S. epidermidis isolates from joint replacement infections carried the qacA/B gene. The MIC/MBC results for all isolates and the qacA/B prevalence rates are presented in Table 4 . A description of biocidal solutions is provided in Table 2 . P a t i e n t s I d u P a t i e n t s C H X N u r s e s I d u N u r s e s C H X P a t i e n t s I d u P a t i e n t s C H X N u r s e s I d u N u r s e s C H X P a t i e n t s I d u P a t i e n t s C H X N u r s e s I d u N u r s e s C H X P a t i e n t s I d u P a t i e n t s C H X N u r s e s I d u N u r s e s C H X Skovgaard et al.
qacA/B genes were not present in S. epidermidis isolates from 1965 to 1966
The consequences of long-term exposure were investigated by examining a collection of Danish S. epidermidis blood isolates from the 1960s. None of the 33 S. epidermidis isolated from blood in 1965-66 were qacA/B positive, while 55% of the 64 current S. epidermidis blood isolates harboured the qacA/B gene. This represented a statistically significant difference, with a P value ,0.0001 (Fisher's exact test) . Again, when comparing the MIC and MBC for a selection of 5 historical isolates and 12 current isolates (6 qacA/B positive and 6 qacA/B negative), the values were very close to each other (Table 4) . Although there were indications that the MIC could be higher in current blood isolates, with P values of 0.029 when measured for Iduscrub and 0.044 when measured for chlorhexidine, this represented differences in means of less than one doubling dilution, and no differences were found in MBC values (Mann-Whitney test).
qacA/B association with antibiotic resistance
Overall the antibiotic resistance profiles of the S. epidermidis from the scrub nurses and the patients before and after hospitalization did not differ. However, when the isolates were grouped according to qacA/B status independent of isolation origin, erythromycin resistance was significantly more prevalent in the qacA/B-positive isolates.
For the blood isolates from 2010 to 2011 the qacA/B-positive isolates were more resistant compared with the qacA/B-negative isolates, with methicillin, gentamicin and moxifloxacin resistance being significantly overrepresented in the qacA/B-positive group. Table 5 presents antibiotic resistance profiles for the different groups of isolates.
Discussion
The main goal of this study was to evaluate if the use of chlorhexidine in the Danish hospital setting has selected for S. epidermidis that are more tolerant towards chlorhexidine and/or harbour the qacA/B gene.
Interestingly, none of 33 S. epidermidis blood isolates from 1965 to 1966 harboured the qacA/B gene, whereas the genes were found in about half of all current isolates. The qac gene was first described about 20 years later, in 1985, in a plasmid from an MRSA, and was proposed to have been selected by extensive application of quaternary ammonium compounds. 27 Since then a qacB-encoding plasmid has been described in a clinical S. aureus strain isolated from a patient in Australia in 1951. 28 The authors compared this plasmid with plasmids from the 1980s, one encoding qacB (pSK23) and one encoding qacA (pSK1). By sequence similarities, as well as the fact that qacA was first isolated in the 1980s and the wider substrate specificity compared with qacB, they proposed that qacA has evolved from qacB and that this correlates with the extensive use in hospital environments of divalent cations such as chlorhexidine, to which qacA, but not qacB, confers tolerance.
It could be claimed that qacA/B-containing plasmids were lost during the long storage period of the blood isolates from the 1960s. Plasmid purification and gel electrophoresis was performed on six current blood isolates and on eight blood isolates stored since 1965 and plasmids were visualized in all isolates apart from two of the old blood isolates (data not shown).
Importantly, we were unable to correlate the use of chlorhexidine in scrub nurses with colonization by S. epidermidis isolates tolerant to chlorhexidine or the presence of qacA/B genes. An explanation for this could be that the scrub nurses are exposed to such high levels of chlorhexidine that it does not make a difference whether they harbour the qacA/B gene or not and/or that the patients have had an unknown exposure to lower levels of chlorhexidine causing a selective pressure. Another explanation could be that other factors, not controlled for in this study, are driving the selective pressure for qacA/B genes.
The prevalence of individuals with qacA/B-positive S. epidermidis was 50% for both scrub nurses (heavy users of chlorhexidine) and patients (non-users of hand disinfectants) before hospitalization and remained at 50% for patients 1 day after surgery. 
Chlorhexidine and Staphylococcus epidermidis
However, this study was designed to detect if scrub nurses were colonized with S. epidermidis showing higher MICs/MBCs for chlorhexidine and was not powered to find a difference between prevalence rates of qacA/B genes in S. epidermidis from scrub nurses and patients. A recent study compared coagulase-negative staphylococci from nurses with a control group, the general population, in Hong Kong. 12 They found that 56.7% of the nurses, but only 13.5% of the general population, were colonized with qacA/B-positive coagulase-negative staphylococci. With a power of 0.80 (a¼ 0.006), the possible difference between qacA/B carriage in this study is less than the 13.5% prevalence of qacA/B in S. epidermidis from patients and 82% from scrub nurses (post hoc analyses performed using G*Power 3.1.5). 29 In this study, we found that 55% of current blood isolates were qacA/B positive. Although 50% of nurses and patients carried at least one isolate with this gene, only 19% -27% of all S. epidermidis isolated from their noses and hands were qacA/B positive (Tables 3  and 4 ). This could indicate that qacA/B-positive isolates were either more prone to cause bloodstream infections or did actually more often escape disinfection/hygiene procedures in relation to, e.g. intravascular catheters. However, this is purely speculative and the causality needs to be proven.
The level of antibiotic-resistant S. epidermidis was the same in scrub nurses and our control patients. However, we did find a significant overrepresentation of resistance to macrolides, gentamicin, moxifloxacin and, importantly, methicillin in qacA/B-positive S. epidermidis. The qacA/B genes are often located on plasmids, with the coexistence of antibiotic resistance genes on the same plasmid. 13 Plasmids are well described as carriers of gentamicin and macrolide resistance and other researchers have found plasmids with the coexistence of gentamicin resistance and chlorhexidine tolerance, 30 as well as the coexistence of qac genes and other antibiotic or heavy metal resistance factors. 31, 32 We wonder what the selective pressures are for qacA/B genes in S. epidermidis in today's Danish general community. One source may be quaternary ammonium compounds used as surfactants in shampoos, hair conditioners and sanitizers for homes. Another source could be the use of macrolides and dyes or maybe other as yet unknown compounds exported by the efflux pump or coselected on the same plasmid. More research into factors selecting for qacA/B genes and the association with antibiotic susceptibility is needed.
In conclusion, the use of chlorhexidine in the Danish hospital setting appears neither to have selected for measurable chlorhexidine tolerance in S. epidermidis nor qacA/B carriage when compared with community isolates. Importantly, the susceptibility of hospital isolates to chlorhexidine was similar to that of community isolates as well as to that of blood isolates obtained in the 1960s before the introduction of chlorhexidine. However, in contrast to current blood isolates, the qacA/B genes were absent in the isolates collected in the 1960s, suggesting that selection has occurred. This is the first study to indicate a recent introduction of qacA/B genes in S. epidermidis and we speculate it may be associated with the use of chlorhexidine or related compounds as has been suggested for S. aureus. 27, 28 
